Increased SPARC expression is associated with neoadjuvant therapy in resectable pancreatic ductal adenocarcinoma.

Hartley, Christopher; Rowan, Daniel; Chen, Xiuxu; Gomez-Arellano, Luisa; West, Anna Marie; Oshima, Kiyoko; Mackinnon, Alexander Craig

Hartley, Christopher; Rowan, Daniel; Chen, Xiuxu; Gomez-Arellano, Luisa; West, Anna Marie; Oshima, Kiyoko; Mackinnon, Alexander Craig.

Afiliação

Hartley C; Medical College of Wisconsin, #University of Alabama at Birmingham, United States.
Rowan D; Medical College of Wisconsin, #University of Alabama at Birmingham, United States.
Chen X; Medical College of Wisconsin, #University of Alabama at Birmingham, United States.
Gomez-Arellano L; Medical College of Wisconsin, #University of Alabama at Birmingham, United States.
West AM; Medical College of Wisconsin, #University of Alabama at Birmingham, United States.
Oshima K; Medical College of Wisconsin, #University of Alabama at Birmingham, United States.
Mackinnon AC; Medical College of Wisconsin, #University of Alabama at Birmingham, United States.

Pract Lab Med ; 21: e00171, 2020 Aug.

Article em En | MEDLINE | ID: mdl-32548230

Palavras-chave

Adjuvant therapy; Digital image analysis; Immunohistochemistry; Neoadjuvant therapy; Pancreatic cancer; SPARC

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pract Lab Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google